STELARA® (ustekinumab) Mechanism of Action: Plaque Psoriasis
Key signaling pathways in psoriasis | PTT
Psoriasis | Nature Reviews Disease Primers
Recent advances in understanding psoriasis | F1000Research
The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses: Trends in Immunology
Frontiers | Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders | Immunology
JCM | Free Full-Text | Molecular Pathogenesis of Psoriasis and Biomarkers Reflecting Disease Activity | HTML
Psoriasis pathogenesis and the development of novel targeted immune therapies - Journal of Allergy and Clinical Immunology
Psoriasis - Wikipedia
Pathogenesis of psoriasis and development of treatment - Ogawa - 2018 - The Journal of Dermatology - Wiley Online Library
Psoriasis - The Lancet
Medicinal Plants to Calm and Treat Psoriasis Disease | IntechOpen
Selenium nanoparticles produce a beneficial effect in psoriasis by reducing epidermal hyperproliferation and inflammation | Journal of Nanobiotechnology | Full Text
Mechanisms of psoriasis - ScienceDirect
Schematic presenting the mechanism of disease relapse following... | Download Scientific Diagram
Psoriasis | NEJM
Psoriasis pathophysiology: current concepts of pathogenesis | Annals of the Rheumatic Diseases
The pathogenesis of psoriatic arthritis - The Lancet
Current knowledge on psoriasis and autoimmune diseases | PTT
Psoriasis and Other Papulosquamous Diseases | Plastic Surgery Key
Mechanisms of psoriasis - ScienceDirect
Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor–modulating agent - Journal of the American Academy of Dermatology
Resolution of plaque-type psoriasis: what is left behind (and reinitiates the disease) | SpringerLink
Resolution of plaque-type psoriasis: what is left behind (and reinitiates the disease) | SpringerLink
Pathogenic Role of Cytokines and Effect of Their Inhibition in Psoriasis | IntechOpen